scholarly journals Evaluation of a Turbidimetric Denka Seiken C-Reactive Protein Assay for Cardiovascular Risk Estimation and Conventional Inflammation Diagnosis

2003 ◽  
Vol 49 (3) ◽  
pp. 511-512 ◽  
Author(s):  
Thomas Christian Vukovich ◽  
Stefan Mustafa ◽  
Helmut Rumpold ◽  
Oswald Wagner
Keyword(s):  
Cardiovascular Risk ◽  
Risk Estimation ◽  
C Reactive Protein ◽  
Protein Assay ◽  
Reactive Protein ◽  
Cardiovascular Risk Estimation

Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay

2006 ◽  
Vol 44 (2) ◽  
Author(s):  
Snežana Jovičić ◽  
Svetlana Ignjatović ◽  
Marijana Dajak ◽  
Nada Majkić-Singh
Keyword(s):  
Cardiovascular Risk ◽  
Clinical Efficacy ◽  
Risk Estimation ◽  
High Sensitivity ◽  
Analytical Performance ◽  
C Reactive Protein ◽  
Cvd Risk ◽  
Reactive Protein ◽  
Deming Regression ◽  
Cardiovascular Risk Estimation

AbstractIncreased C-reactive protein (CRP) concentration within the reference interval (<10.0mg/L) is a strong predictor of cardiovascular disease (CVD) in apparently healthy adults. Cutoff points for use of CRP in estimating CVD risk are <1, 1–3 and >3mg/L for low, average and high relative risk, respectively. For measuring CRP concentrations to assess cardiovascular risk, high-sensitivity CRP (hsCRP) assays have been developed. The aim of this study was to evaluate the analytical performance and clinical efficacy for cardiovascular risk estimation of the Olympus immunoturbidimetric latex CRP assay (sensitive application). The comparative method used was the CardioPhase* hsCRP assay, approved by the Food and Drug Administration for use in CVD risk assessment. The imprecision of the Olympus hsCRP assay in the concentration range 0.2–10.0mg/L was 0.38–8.16% within runs and 3.75–9.63% between runs. For method comparison studies, 194 fresh serum samples were selected to cover the interval 0.15–10.0mg/L CRP. Comparison of the Dade Behring and Olympus methods was performed using weighted Deming regression analysis (slope 0.99mg/L, intercept 0.002mg/L, S

scholarly journals Evaluation of Turbidimetric High-Sensitivity C-Reactive Protein Assays for Cardiovascular Risk Estimation

2001 ◽  
Vol 47 (11) ◽  
pp. 2044-2046 ◽  
Author(s):  
Ahmad Hamwi ◽  
Thomas Vukovich ◽  
Oswald Wagner ◽  
Helmut Rumpold ◽  
Roswitha Spies ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Risk Estimation ◽  
High Sensitivity ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Protein Assays ◽  
Cardiovascular Risk Estimation

scholarly journals 1117-86 Do differing C-reactive protein assay methods impact cardiovascular risk assessment?

2004 ◽  
Vol 43 (5) ◽  
pp. A288 ◽  
Author(s):  
Jessica L Clarke ◽  
Jeffrey L Anderson ◽  
John F Carlquist ◽  
Richard F Roberts ◽  
Benjamin D Horne ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Cardiovascular Risk ◽  
C Reactive Protein ◽  
Cardiovascular Risk Assessment ◽  
Protein Assay ◽  
Reactive Protein ◽  
Assay Methods

Comparison of differing C-reactive protein assay methods and their impact on cardiovascular risk assessment

2005 ◽  
Vol 95 (1) ◽  
pp. 155-158 ◽  
Author(s):  
Jessica L. Clarke ◽  
Jeffrey L. Anderson ◽  
John F. Carlquist ◽  
Richard F. Roberts ◽  
Benjamin D. Horne ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Cardiovascular Risk ◽  
C Reactive Protein ◽  
Cardiovascular Risk Assessment ◽  
Protein Assay ◽  
Reactive Protein ◽  
Assay Methods
Sign in / Sign up

Export Citation Format

Share Document